Compare
Regulatory professionals weigh three alternatives: a generic AI chatbot, the free FDA websites, or a five-figure enterprise database. Here is where Compliome fits, and where it honestly doesn't.
| Feature | Compliome | Generic AI(ChatGPT, Perplexity, NotebookLM) | Free FDA sources(eCFR, openFDA, ClinicalTrials.gov) | Enterprise reg-intel(legacy databases) |
|---|---|---|---|---|
| Purpose-built for FDA / 21 CFR | — | |||
| Cited answers traceable to the primary source | Web links it found | It is the source | ||
| Deterministic links to the exact CFR section / FDA PDF | — | Varies | ||
| Unified: regs + guidance + 510(k)/PMA + drugs + pharmacology + enforcement + trials + intl | — | Separate silos | Usually one slice | |
| Interactive knowledge-engine visualization | — | — | — | |
| Hybrid semantic + keyword retrieval over a curated corpus | Open web | — | ||
| Always-current automated ingestion (no manual uploads) | Web-dependent | |||
| Simple signup, no sales calls or procurement | — | |||
| Affordable for individuals & small teams | Free in beta | $0–20/mo | Free | $10K–100K+/yr |
Comparison reflects typical capabilities of each category as of 2026. Compliome is an informational research tool, not legal or regulatory advice.
ChatGPT, Perplexity, and NotebookLM are capable generalists, but they have no curated FDA corpus. Citations are web links they happened to find — or only the documents you upload — and section text can be paraphrased or wrong. For compliance-critical work, an unverifiable citation is a liability. Compliome grounds every answer in the actual regulatory record and links to the exact source.
eCFR, openFDA, and ClinicalTrials.gov are authoritative, and they are exactly the data Compliome ingests. But they live in separate interfaces with no natural-language layer and no connections between them. Compliome unifies them, adds cited synthesis, and maps how a rule connects to guidance, devices, drugs, enforcement, and trials in one interactive knowledge engine.
The legacy platforms are powerful but priced for Big Pharma: five to six figures a year, gated behind sales calls and long procurement cycles, and none of them visualize the relationships between regulations. Compliome delivers cited, evidence-based research with an interactive knowledge engine you can start with a beta invite — no procurement cycle or five-figure contract.
The difference
Plenty of tools now bolt an AI chatbot onto regulatory content. None of the affordable ones pair verifiable, primary-source citations with an interactive knowledge engine spanning 21 CFR, FDA guidance, device clearances, drug approvals, drug pharmacology, enforcement, clinical trials, and international sources. That combination is what makes Compliome different.